In:
International Journal of Cancer, Wiley, Vol. 141, No. 2 ( 2017-07-15), p. 254-263
Abstract:
What's new? Because diabetes is common, many cancer patients face a dual challenge of managing their blood sugar while fighting cancer. Metformin is a medication commonly prescribed to treat diabetes, and also has anticancer properties. These authors investigated whether metformin improves survival among non‐small cell lung cancer patients, using data from the US Military Health System. Patients taking metformin survived longer than those not using the drug, they found, particularly those who were already taking metformin before their cancer diagnosis. The longer a person had been taking metformin, the more their risk was reduced.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8
Permalink